Booking Holdings Inc.
BKNG · NASDAQ
Analyst ratings
strong_buy · 28 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 14, 2026 | Jefferies | Maintains | Hold | $190.00 |
| June 30, 2026 | Wells Fargo | Maintains | Equal-Weight | $214.00 |
| May 29, 2026 | BTIG | Reiterates | Buy | $250.00 |
| April 30, 2026 | Argus Research | Maintains | Buy | $205.00 |
| April 29, 2026 | JP Morgan | Maintains | Overweight | $208.00 |
| April 29, 2026 | UBS | Maintains | Buy | $249.00 |
| April 29, 2026 | TD Cowen | Maintains | Buy | $230.00 |
| April 29, 2026 | RBC Capital | Maintains | Outperform | $220.00 |
| April 29, 2026 | Citigroup | Maintains | Buy | $225.00 |
| April 29, 2026 | Oppenheimer | Maintains | Outperform | $215.00 |
| April 29, 2026 | Wells Fargo | Maintains | Equal-Weight | $215.00 |
| April 29, 2026 | Evercore ISI Group | Maintains | Outperform | $245.00 |
| April 29, 2026 | Cantor Fitzgerald | Maintains | Neutral | $175.00 |
| April 29, 2026 | Barclays | Maintains | Overweight | $210.00 |
| April 29, 2026 | DA Davidson | Maintains | Buy | $230.00 |
| April 29, 2026 | Baird | Maintains | Outperform | $215.00 |
| April 29, 2026 | BTIG | Reiterates | Buy | $250.00 |
| April 27, 2026 | UBS | Maintains | Buy | $260.00 |
| April 27, 2026 | B. Riley Securities | Maintains | Buy | $264.00 |
| April 21, 2026 | Deutsche Bank | Maintains | Buy | $210.00 |
| April 14, 2026 | Wells Fargo | Maintains | Equal-Weight | $214.00 |
| April 10, 2026 | B. Riley Securities | Maintains | Buy | $272.00 |
| April 8, 2026 | Tigress Financial | Maintains | Strong Buy | $260.00 |
| April 8, 2026 | DA Davidson | Maintains | Buy | $240.00 |
| April 7, 2026 | BTIG | Reiterates | Buy | $250.00 |
| April 6, 2026 | Truist Securities | Maintains | Buy | $231.20 |
| April 6, 2026 | Bernstein | Maintains | Market Perform | $188.00 |
| April 1, 2026 | Wells Fargo | Maintains | Equal-Weight | $215.08 |
| March 3, 2026 | BTIG | Reiterates | Buy | $250.00 |
| February 24, 2026 | Morgan Stanley | Upgrades | Overweight | $220.00 |
| February 20, 2026 | JP Morgan | Maintains | Overweight | $5,600.00 |
| February 20, 2026 | Susquehanna | Maintains | Positive | $200.00 |
| February 19, 2026 | UBS | Maintains | Buy | $259.40 |
| February 19, 2026 | Citigroup | Maintains | Buy | $250.00 |
| February 19, 2026 | Benchmark | Maintains | Buy | $224.00 |
| February 19, 2026 | Piper Sandler | Reiterates | Neutral | $200.00 |
| February 19, 2026 | Oppenheimer | Maintains | Outperform | $240.00 |
| February 19, 2026 | RBC Capital | Reiterates | Outperform | $244.00 |
| February 19, 2026 | Barclays | Maintains | Overweight | $220.00 |
| February 19, 2026 | Wells Fargo | Maintains | Equal-Weight | $218.24 |
| February 19, 2026 | Cantor Fitzgerald | Maintains | Neutral | $179.80 |
| February 19, 2026 | BMO Capital | Maintains | Outperform | $248.00 |
| February 19, 2026 | DA Davidson | Maintains | Buy | $240.00 |
| February 19, 2026 | BTIG | Reiterates | Buy | $250.00 |
| February 13, 2026 | BTIG | Reiterates | Buy | $250.00 |
| February 6, 2026 | Wedbush | Maintains | Outperform | $220.00 |
| February 4, 2026 | Keybanc | Maintains | Overweight | $260.00 |
| February 3, 2026 | UBS | Maintains | Buy | $264.32 |
| January 9, 2026 | Wells Fargo | Maintains | Equal-Weight | $238.16 |
| January 8, 2026 | Cantor Fitzgerald | Maintains | Neutral | $233.20 |
| January 6, 2026 | Argus Research | Maintains | Buy | $256.00 |
| January 6, 2026 | Bernstein | Maintains | Market Perform | $216.28 |
| December 23, 2025 | BTIG | Reiterates | Buy | $250.00 |
| November 24, 2025 | B of A Securities | Upgrades | Buy | $240.00 |
| November 24, 2025 | BTIG | Reiterates | Buy | $250.00 |
| November 13, 2025 | Wedbush | Upgrades | Outperform | $240.00 |
| October 29, 2025 | UBS | Maintains | Buy | $272.24 |
| October 29, 2025 | Benchmark | Maintains | Buy | $256.00 |
| October 29, 2025 | Truist Securities | Maintains | Buy | $232.40 |
| October 29, 2025 | Wells Fargo | Maintains | Equal-Weight | $220.92 |
| October 29, 2025 | Cantor Fitzgerald | Maintains | Neutral | $222.00 |
| October 29, 2025 | Barclays | Maintains | Overweight | $250.00 |
| October 29, 2025 | Keybanc | Maintains | Overweight | $265.20 |
| October 29, 2025 | DA Davidson | Maintains | Buy | $264.00 |
| October 29, 2025 | BTIG | Reiterates | Buy | $250.00 |
| October 27, 2025 | Truist Securities | Upgrades | Buy | $230.00 |
| October 24, 2025 | UBS | Maintains | Buy | $269.72 |
| October 22, 2025 | Cantor Fitzgerald | Maintains | Neutral | $223.60 |
| October 8, 2025 | BTIG | Reiterates | Buy | $250.00 |
| October 6, 2025 | Wells Fargo | Maintains | Equal-Weight | $217.72 |
| September 4, 2025 | BTIG | Reiterates | Buy | $250.00 |
Middle East conflict impact: Transitory headwind or structural demand erosion?
The Middle East conflict's drag on room nights is a temporary disruption, not a fundamental shift. Management estimates underlying growth near 8%, above the 5–7% guidance range, and Wall Street has maintained 25 buy ratings with a mean price target of $224, treating the conflict impact as short-lived rather than structural.
The conflict's impact is widening, with Q2 guidance assuming a 3-point drag on room nights — larger than Q1's 2-point impact. Full-year guidance was cut at the midpoint, and the stock hit a 33% maximum drawdown in May 2026, reflecting meaningful near-term earnings risk that may persist if geopolitical tensions are prolonged.
AI disruption risk to Booking Holdings' core platform and competitive moat
Booking Holdings holds a dominant market position with $26.92B in revenue and a 22.23% net margin in 2025, underpinned by OpenTable growth and strong travel industry trends. Analyst consensus remains firmly positive, with 64% buy ratings, suggesting confidence that the platform's scale and brand can withstand AI-driven competitive shifts.
AI disruption is cited as a key risk to Booking Holdings' business model, potentially enabling new entrants or search engines to disintermediate traditional online travel agents. Combined with a high debt-to-asset ratio of 64%, the company may face margin pressure if it needs to invest heavily in AI capabilities to defend its position.
Earnings trajectory and valuation: Compelling upside or overestimated growth?
Earnings per share are forecast to surge from $119 to $177 next year, representing significant year-over-year growth. TIKR's mid-case model values the stock at $371 by December 2030, implying a 101% total return or 17% annualized, well above typical market expectations for a company with high-30s EBITDA margins.
Financhill's model rates BKNG a Sell with a Stock Score of 50/100, flagging higher-than-normal risk. Analysts estimate an earnings decrease both this quarter and this year, and the stock has risen in only 16 of the past 27 years over a subsequent 52-week period — a success rate of just 59% — raising doubts about near-term upside conviction.